London-based medtech startup Mendelian gets more than half a million to detect rare diseases faster
The London-based medtech startup Mendelian is on the mission to improve the lives of patients by diagnosing rare diseases faster.
Popular topics
Health technology, digital therapeutics, biotech, and the slow remaking of medical practice through software and devices.
705 articles · Health Tech & Medtech
The London-based medtech startup Mendelian is on the mission to improve the lives of patients by diagnosing rare diseases faster.
In the latest development, LIOF, a regional development and investment company in Maastricht will finance Limburg medtech startup through the Limburg Business Development Fund (LBDF) for the development of a virtual reality application in psychological care, which is being developed at the Brightlands Smart Services Campus in Heerlen.
Wrocław-based medtech startup Genomtec has developed an innovative mobile device that can detect deadly pathogens in just 20 minutes.
It seems the technology and hardware continue to evolve and expand in ways that benefit everyone including the radiologists.
AXA Venture Partners (AVP) is a venture capital firm with its presence in several countries has invested in many high-growth technology companies.
Recently, Kaia Health, a digital therapeutics company focused on Artificial Intelligence (AI) has pulled in €8.8 million in a Series A round led by Balderton Capital.
With every passing day, the number of cardiac patients are escalating globally.
Based out of Belgium, Phasya, a company which develops drowsiness detection software has raised €967,000 in equity from several private and institutional investors.
Stockholm-based e-pharmacy Meds has bagged €5 million in a funding round led by Inbox Capital.
Galway-based Medtech startup Atlantic Therapeutics has obtained €28 million in Series B funding following FDA’s green signal for its garment-based device that treats incontinence.
Shift Invest, an open-innovation investment platform has invested in the U.K startup Changing Health.
Lausanne-based clinical-stage biopharmaceutical startup Oculis has secured €13.8 million in Series B annexe funding round by led Tekla Capital Management, with participation from Nan Fung Life Sciences and existing investors.